Trade OABI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
OmniAb, Inc. (OABI) is trading at US$4.43, down 4.01% today as of Aug 28, 12:59 EDT. The company has a market capitalisation of US$629.54M. Over the past 52 weeks, OABI has traded between US$1.30 and US$4.93. On Syfe you can trade OABI with $0 commission and add it to your watchlist.
| Previous close | US$4.61 |
|---|---|
| Market cap | US$629.54M |
| 52-week range | US$1.30 – US$4.93 |
| Volume | 1.28M |
| Exchange | US |
Add to Watchlist
Set Price Alert
OmniAb, Inc.
OmniAb, Inc. operates as a drug discovery company. The firm focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.
Year: 2022
OmniAb, Inc. (OABI) stock is trading at US$4.43, -4.01% from the previous close of US$4.61.
The market cap for OmniAb, Inc. (OABI) stock is approximately US$629.54M.
The 52-week high for OmniAb, Inc. (OABI) stock is US$4.93.
The 52-week low for OmniAb, Inc. (OABI) stock is US$1.30.
OmniAb, Inc. (OABI) does not currently pay a dividend.
Stay on top of OABI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
